Identification of an HLA-A*11:01-Restricted Neoepitope of Mutant PIK3CA and Its Specific T Cell Receptors for Cancer Immunotherapy Targeting Hotspot Driver Mutations

0
17
Using in vitro stimulation, antigen-specific T cells targeting the HLA-A*11:01-restricted PIK3CA mutation were isolated from healthy donor-derived peripheral blood mononuclear cells.
[Cancer Immunology Immunotherapy]
Full Article